Thus, as per the study design, patients and controls were matched for age at the time of liver biopsy ( Table 1). Other matched variables included gender, genotype and fibrosis stage. Of the ...

Blood-based biomarkers offer a number of advantages over the traditional standard of fibrosis assessment of liver biopsy, including safety, cost-savings and wide spread accessibility. Current ...

Aug. 21, 2024 — A research team has shown the benefits of camu-camu on non-alcoholic fatty liver disease. This exotic fruit reduces liver fat ... Liver Transplant Outperforms Other Therapies for ...

Patients receiving VK2809 demonstrated statistically significant reductions in liver fat at Week 12, which was the primary endpoint in VOYAGE. Importantly, patients receiving VK2809 continued to ...

2015;47(10):2886-91. Therefore, this study aimed to determine the incidence and independent risk factors for concurrent NAFLD among CHB patients who underwent liver biopsy and investigated the ...

Secondary objectives include the evaluation of histologic changes assessed by hepatic biopsy after 52 weeks of treatment. VK2809 is an orally available, tissue and receptor-subtype selective ...